Zerion Pharma A/S: Financial statements 2025
CVR: 40169229
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Zerion Pharma A/S (CVR 40169229) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. That is a decrease of 2.2% compared with the year before. The profit margin was -320.6%. Equity in the 2025 report amounted to DKK -3,511,410. The company had 10 employees in the financial year.
- Revenue
- DKK 3,377,646
- Gross Profit
- DKK -4,791,580
- Profit/Loss
- DKK -10,830,354
- Equity
- DKK -3,511,410
- Total Assets
- DKK 11,054,896
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 3.4 mio. | -4.8 mio. | -10.8 mio. | -3.5 mio. | 10 |
| 2024 | 3.5 mio. | -5.8 mio. | -220 t. | -2.3 mio. | 12 |
| 2023 | 3.6 mio. | -5.3 mio. | -11.1 mio. | -13.7 mio. | 11 |
| 2022 | 3.3 mio. | -10.9 mio. | -18.9 mio. | -10 mio. | 12 |
| 2021 | 1.9 mio. | -6.7 mio. | -11.1 mio. | -867 t. | 8 |
Official annual report
How creditworthy is Zerion Pharma A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Zerion Pharma A/S has published its annual report for 2024. Revenue came to DKK 3,452,016, and the net result was DKK -220,020.
As of June 25, 2025, Geelanie Rodriguez Briones has joined the board of directors of Zerion Pharma A/S.
As of June 25, 2025, Lars Lykke Thomsen has left the board of directors of Zerion Pharma A/S.
As of June 24, 2025, Geelanie Rodriguez Briones has left the board of directors of Zerion Pharma A/S.
As of February 5, 2025, Geelanie Rodriguez Briones has joined the board of directors of Zerion Pharma A/S.
As of February 5, 2025, Geelanie Rodriguez Briones is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
About Zerion Pharma A/S
Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The board consists of Carl-Åke Carlsson (chair), Geelanie Rodriguez Briones, Allan Stich and Dorte Juhl Arnbjerg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. The company has 15 employees (2026). In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity in the 2025 report amounted to DKK -3,511,410.